|
National
Biotech Strategy envisages measures to raise investments
The National Biotech Strategy proposes a series of initiatives to
peg up investment in the sector and to strengthen human resources
with an objective of achieving a turnover of $5 billion and creation
of one billion jobs by 2010.
ICMR
throws spanner into IISc’s scheme on rifampicin, INH against
malaria
The Bangalore based Indian Institute of Science (IISc) effort to
use rifampicin and INH (isoniazid), the drugs used in tuberculosis,
for fighting malaria caused by chloroquin-resistant Plasmodium falciparum
in direct human clinical trials received a set back as the Indian
Council of Medical Research (ICMR) has asked them to do trials in
primates first.
TDB
joins hands with APIDC-VCL for co-investment scheme
The Technology Development Board, under the Department of Science
& Technology, has allied with APIDC Venture Capital Ltd to provide
financial support to technology projects through a Co-Investment
Scheme.
A
wave of change hits pharma industry, triggers hope for better growth
Faced with at least three regime changes simultaneously giving the
initial impression of total chaos for the Indian pharmaceutical
industry, experts feel that this will lead to a better regime for
overall growth.
|
